Motorola Solutions (MSI) Valuation Rose While Orbis Investment Management Lowered Stake; As Teva Pharmaceutical (TEVA) Share Value Rose, Northern Cross Lifted by $39.18 Million Its Position

June 14, 2018 - By Vivian Park

Motorola Solutions, Inc. (NYSE:MSI) Logo

William B. Gray decreased its stake in Motorola Solutions Inc (MSI) by 70.96% based on its latest 2018Q1 regulatory filing with the SEC. Orbis Investment Management sold 56,144 shares as the company’s stock rose 3.51% while stock markets declined. The hedge fund run by William B. Gray held 22,980 shares of the technology company at the end of 2018Q1, valued at $2.42M, down from 79,124 at the end of the previous reported quarter. Orbis Investment Management who had been investing in Motorola Solutions Inc for a number of months, seems to be less bullish one the $18.44B market cap company. The stock increased 0.57% or $0.65 during the last trading session, reaching $113.76. About 354,208 shares traded. Motorola Solutions, Inc. (NYSE:MSI) has risen 34.40% since June 14, 2017 and is uptrending. It has outperformed by 21.83% the S&P500. Some Historical MSI News: 19/03/2018 – RadioResource: Kelly Honored by IACP, Motorola; 08/03/2018 – 9to5Google: Rumors of Motorola layoffs swirl as future of Moto Z line potentially in jeopardy; 30/05/2018 – MSI’s BoCommLife Deal in Line with Insurers’ Strategy but Contribution Limited in the Short Term; 16/04/2018 – TESARO: Activity of TSR-042 Monotherapy Demonstrated in Patients With MSI-high Endometrial and Non-Small Cell Lung Cancers; 15/03/2018 – RadioResource: Motorola Accuses Hytera of Filing Anticompetitive Practices Lawsuit as Retaliation; 03/05/2018 – Motorola Solutions Raises FY18 View To Adj EPS $6.70-Adj EPS $6.85; 17/05/2018 – Hot Hardware: MSI Launches AMD-Exclusive Radeon RX MECH 2 Series Polaris Graphics Cards; 03/05/2018 – Motorola Solutions 1Q EPS 69c; 18/05/2018 – USPTO’s Patent Trial and Appeal Board Accepts Petitions of Global PMR Communications Provider Hytera, Initiates lnvalidity Proceedings for Key Motorola Solutions Patents; 03/05/2018 – MOTOROLA SOLUTIONS INC – COMPANY ENDED QUARTER WITH BACKLOG OF $9.6 BLN, UP $1.1 BLN FROM YEAR-AGO QUARTER

Northern Cross Llc increased its stake in Teva Pharmaceutical (TEVA) by 10.38% based on its latest 2018Q1 regulatory filing with the SEC. Northern Cross Llc bought 2.30M shares as the company’s stock rose 10.90% while stock markets declined. The institutional investor held 24.50 million shares of the major pharmaceuticals company at the end of 2018Q1, valued at $418.69 million, up from 22.19M at the end of the previous reported quarter. Northern Cross Llc who had been investing in Teva Pharmaceutical for a number of months, seems to be bullish on the $24.26B market cap company. The stock decreased 2.10% or $0.51 during the last trading session, reaching $23.82. About 9.74M shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 22.74% since June 14, 2017 and is downtrending. It has underperformed by 35.31% the S&P500. Some Historical TEVA News: 19/04/2018 – TEVA & PROCTER & GAMBLE CO. HAVE AGREED TO TERMINATE PGT; 07/03/2018 – XENON PHARMA – CO, TEVA PHARMACEUTICALS INTERNATIONAL GMBH, TEVA CANADA, ENTERED DEAL TO MUTUALLY TERMINATE DEC 7, 2012 DEVELOPMENT & LICENSE AGREEMENT; 21/04/2018 – MYLAN: GLATIRAMER ACETATE DATA FURTHER SUPPORTS FDA’S APPROVAL; 10/04/2018 – Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma; 05/03/2018 Salmeterol Sales, Price Analysis, & Sales Forecast 2016-2021 – ResearchAndMarkets.com; 07/03/2018 – Million Dollar Asterisk Could Hurt Teva as It Sells Junk Bonds; 03/05/2018 – TEVA PHARM: NO EXPECTATION FOR ANOTHER 40 MG GENERIC VERSION OF COPAXONE IN 2018; 15/04/2018 – Israeli unions warn Teva Pharm over plan to close Ashdod plant; 15/05/2018 – Buffett’s Berkshire adds to stakes in Teva and Monsanto in the first quarter; 16/03/2018 – Fitch Rates Teva Pharmaceutical Finance’s Sr Unsecured Notes ‘BB’/’RR4’

Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 8 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 157 analyst reports since July 21, 2015 according to SRatingsIntel. As per Thursday, February 15, the company rating was maintained by Mizuho. RBC Capital Markets maintained it with “Underperform” rating and $15 target in Monday, September 18 report. Cowen & Co downgraded the shares of TEVA in report on Friday, August 4 to “Market Perform” rating. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) has “Overweight” rating given on Wednesday, July 29 by Morgan Stanley. Mizuho maintained the stock with “Neutral” rating in Friday, November 17 report. As per Wednesday, August 2, the company rating was maintained by Mizuho. The rating was maintained by Oppenheimer on Friday, July 14 with “Buy”. The firm has “Neutral” rating by BTIG Research given on Friday, April 7. The firm has “Underweight” rating by JP Morgan given on Monday, November 13. Maxim Group maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Monday, July 27 with “Buy” rating.

More notable recent Teva Pharmaceutical Industries Limited (NYSE:TEVA) news were published by: Globes.Co.Il which released: “Tue: Teva rally fails to lift TASE” on June 12, 2018, also Seekingalpha.com with their article: “Buy Alibaba – Cramer’s Lightning Round (6/12/18)” published on June 13, 2018, Finance.Yahoo.com published: “Warren Buffett Loves TEVA Stock and You Should Too” on May 23, 2018. More interesting news about Teva Pharmaceutical Industries Limited (NYSE:TEVA) were released by: Fool.com and their article: “The Cheapest Drug Stocks to Buy Right Now” published on June 11, 2018 as well as 247Wallst.com‘s news article titled: “Major Pharmaceuticals Scare Off Short Sellers” with publication date: June 12, 2018.

Northern Cross Llc, which manages about $51.96B and $6.09 billion US Long portfolio, decreased its stake in Wynn Resorts Ltd (NASDAQ:WYNN) by 2.16M shares to 4.94 million shares, valued at $900.82 million in 2018Q1, according to the filing. It also reduced its holding in Schlumberger Ltd (NYSE:SLB) by 615,248 shares in the quarter, leaving it with 19.24 million shares, and cut its stake in Alibaba Group Holding (NYSE:BABA).

Among 19 analysts covering Motorola Solutions (NYSE:MSI), 13 have Buy rating, 1 Sell and 5 Hold. Therefore 68% are positive. Motorola Solutions had 53 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Macquarie Research given on Wednesday, February 24. Deutsche Bank upgraded the shares of MSI in report on Friday, January 12 to “Buy” rating. Argus Research maintained the stock with “Buy” rating in Thursday, February 25 report. On Friday, February 2 the stock rating was maintained by Cowen & Co with “Hold”. The firm has “Buy” rating given on Thursday, June 22 by BMO Capital Markets. The stock of Motorola Solutions, Inc. (NYSE:MSI) earned “Hold” rating by Gabelli on Monday, December 7. Deutsche Bank maintained it with “Buy” rating and $125 target in Thursday, March 1 report. The company was maintained on Friday, March 9 by Citigroup. The rating was maintained by Goldman Sachs on Friday, February 3 with “Buy”. Northcoast upgraded the stock to “Buy” rating in Tuesday, May 30 report.

More news for Motorola Solutions, Inc. (NYSE:MSI) were recently published by: Investingnews.com, which released: “3 Cybersecurity ETFs for Investors” on June 14, 2018. Nasdaq.com‘s article titled: “Factors of Influence in 2018, Key Indicators and Opportunity within Regency Centers, Motorola Solutions, California …” and published on June 12, 2018 is yet another important article.

Analysts await Motorola Solutions, Inc. (NYSE:MSI) to report earnings on August, 2. They expect $1.31 earnings per share, up 23.58% or $0.25 from last year’s $1.06 per share. MSI’s profit will be $212.39 million for 21.71 P/E if the $1.31 EPS becomes a reality. After $1.02 actual earnings per share reported by Motorola Solutions, Inc. for the previous quarter, Wall Street now forecasts 28.43% EPS growth.

Motorola Solutions, Inc. (NYSE:MSI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.